Stay updated on Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-19T21:44:39.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.1 instead of v3.7.0. The study record remains unavailable because the page displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T04:18:07.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with an access-denied page. This makes the study information and locations inaccessible to users.
    Difference
    19%
    Check dated 2026-09-21T22:13:51.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a patch-level update to the page. This update appears to be administrative rather than a modification to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T17:28:36.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A new funding entry '2016 ( U.S. NIH Grant/Contract )' was added to the study's funding information, indicating NIH support.
    Difference
    0.1%
    Check dated 2026-08-24T19:15:45.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - The page revision tag was updated from v3.6.4 to v3.6.5, indicating a newer version of the study record. This is a minor revision that does not alter the substantive trial details.
    Difference
    0.0%
    Check dated 2026-08-10T12:43:56.000Z thumbnail image

Stay in the know with updates to Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib Response in BRCA Methylation Breast Cancer Clinical Trial page.